Skip to main content

New CEO takes office today

Tarik Cengiz takes office today as the new CEO of VibroSense Dynamics, which is part of strengthening the organization with a focus on distributors and OEM customers.

Tarik Cengiz will work on developing existing partnerships in the company's current markets. He will also put a lot of focus on driving a geographic expansion and increased sales by addressing potential international partners such as distributors, agents or OEM partners.

"I would like to warmly welcome Tarik to VibroSense, both I and the board look forward to working together with him when VibroSense now clearly focuses on distributors and new markets. The board and I would also like to thank Hans Wallin for all the time and care he put in to move the company forward during sometimes very tough times," says Håkan Petersson, chairman of the board of VibroSense Dynamics AB.

"I look forward to starting to work actively on taking VibroSense to a new phase in the company's development and I am really excited and happy to take on my new assignment. I see a great need for what VibroSense offers the market and good opportunities to develop and expand the business. The goal is to create growth with good profitability," says Tarik Cengiz , CEO of VibroSense Dynamics.

Contact
Håkan Petersson, Chairman of the Board VibroSense Dynamics AB,
Tel: +46 40 88 026 E-mail: info@vibrosense.com

www.vibrosense.com

"The new Gold Standard for reliable
detection of nerve damage"

About VibroSense Dynamics AB (pub)
VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.

Our vision is for the company's products to be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.